Use of the approved injection therapy Empaveli (pegcetacoplan) appears to be effective and generally safe for people with paroxysmal nocturnal hemoglobinuria (PNH) — especially for patients who, despite treatments, have ongoing destruction of red blood cells, known as hemolysis. Those are the findings of a new analysis from…
Discussion
When I was diagnosed with paroxysmal nocturnal hemoglobinuria (PNH) in 2017, I expected the physical challenges. I knew there would be doctor appointments, medications, blood tests, and uncertainty about the future. What I didn’t expect was how much PNH would affect my self-esteem. Before my diagnosis, I was…
Discussion
Treatment with Soliris (eculizumab) appears to help reduce the risk of potentially life-threatening thromboembolic events (TEs), complications caused by clots that disrupt circulation, in people with paroxysmal nocturnal hemoglobinuria (PNH), but it does not eliminate that risk, according to a post-marketing surveillance study from Japan. Researchers found that…
Discussion
One of the toughest questions I’ve faced with paroxysmal nocturnal hemoglobinuria (PNH) isn’t if my treatment is working. It’s whether the symptoms I continue experiencing are left over from the disease or whether I’ve simply become accustomed to not feeling well. When you live with a rare chronic illness…
Get regular updates delivered to your inbox.
